Literature DB >> 3260678

Changes in T-cell subsets after radiation therapy.

S J Yang1, S Rafla, E Youssef, H Selim, N Salloum, J Y Chuang.   

Abstract

The T-cell subsets of 129 patients with cancer were counted before and after radiation therapy. The cells were labeled with monoclonal antibodies that were specific for each type of T cell. Significant changes after therapy were decreases in the proportion of T-helper/inducer cells, pan-T cells, and in the ratio of T-helper/inducer to T-suppressor/cytotoxic cells. There was an increase in the percentage of T-suppressor/cytotoxic cells. When the site of the primary cancer was considered, genitourinary cancer and cancer of the head and neck both showed a decreased percentage of T-helper/inducer cells and a reduced ratio of T-helper/inducer to T-suppressor/cytotoxic cells. The percentage of pan-T cells in head and neck cancer and the ratio of T-helper/inducer to T-suppressor/cytotoxic cells in breast cancer were decreased. The percentage of T-helper cells was particularly decreased by radiation therapy in advanced stages of cancer, in higher grade tumors, and in larger tumors. The absolute numbers of various T-cell subsets were decreased in all groups.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260678     DOI: 10.1148/radiology.168.2.3260678

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  Combining immunotherapy with radiation for the treatment of glioblastoma.

Authors:  Kevin K H Chow; Wendy Hara; Michael Lim; Gordon Li
Journal:  J Neurooncol       Date:  2015-04-17       Impact factor: 4.130

2.  Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.

Authors:  Jian L Campian; Guneet Sarai; Xiaobu Ye; Shanthi Marur; Stuart A Grossman
Journal:  Head Neck       Date:  2014-04-15       Impact factor: 3.147

3.  Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen.

Authors:  J Lukac; Z Kusić; D Kordić; M Koncar; A Bolanca
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 4.  Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary?

Authors:  Nadine Housri; Robert Yarchoan; Aradhana Kaushal
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

5.  Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era.

Authors:  Keri L Calkins; Geetanjali Chander; Corinne E Joshu; Kala Visvanathan; Anthony T Fojo; Catherine R Lesko; Richard D Moore; Bryan Lau
Journal:  JAMA Oncol       Date:  2020-02-01       Impact factor: 31.777

6.  Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy.

Authors:  Qianqian Zhao; Tingting Li; Gang Chen; Zhaochong Zeng; Jian He
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

7.  Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy.

Authors:  Maximilian Knoll; Maria Waltenberger; Jennifer Furkel; Ute Wirkner; Aoife Ward Gahlawat; Ivana Dokic; Christian Schwager; Sebastian Adeberg; Stefan Rieken; Tobias Kessler; Felix Sahm; Laila König; Christel Herold-Mende; Stephanie E Combs; Jürgen Debus; Amir Abdollahi
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.